Neidio i’r brif dudalen lywio
Neidio i chwilio
Neidio i’r prif gynnwys
Trefnu yn ôl
Keyphrases
Rapid Review
63%
Wales
45%
Cost-effectiveness
43%
COVID-19
35%
Rapid Evidence Review
33%
Randomized Controlled Trial
29%
Carers
29%
Dementia
27%
Discrete Choice Experiment
26%
Policy Decisions
24%
Bespoke
24%
Lessons Learned
23%
Healthcare
21%
Patient Preference
20%
Clinical Care
20%
Living with
19%
Clinical Outcomes
18%
National Health Service
18%
Dementia Carers
17%
Risk of Bias
17%
Well-being
17%
Alternative Care Pathways
17%
Decision Maker
17%
People with Dementia
16%
Review Process
16%
COVID-19 Pandemic
16%
Supporting People
15%
Self-monitoring
15%
Urate
15%
Gout
15%
Cancer Survivors
15%
Care Pathway
15%
Technology Assessment
15%
Engaging Stakeholders
15%
Clinical Decision-making
15%
Environmental Research
15%
Trial Design
15%
MHealth Intervention
15%
Quality-adjusted Life Years
14%
Epilepsy
14%
Physical Activity
14%
Evidence Review
14%
Copyright
13%
Mental Health
12%
Phase II Trial
12%
Primary Progressive Aphasia
12%
Posterior Cortical Atrophy
12%
Seizure
12%
General Public
12%
Primary Care
11%
Measuring Instrument
11%
Cancer Detection
11%
Randomized Trial
11%
Knowledge Exchange
10%
United Kingdom
10%
Medical Records
10%
Rare Dementia
10%
Policy Decision-making
10%
Intervention Group
10%
Process Evaluation
10%
Economic Analysis
10%
Knowledge Mobilization
10%
Economic Impact
10%
Quality of Life
9%
Support Services
9%
Social Care
9%
Service User Preferences
9%
Practice-based
9%
Caregivers
9%
Opioids
9%
Health Technology Assessment
9%
Cost-utility Analysis
9%
Qualitative Interviews
9%
Potential Type
9%
Causal Effect
9%
Personal Assistant
9%
Adverse Events
8%
Evidence-based Policy
8%
In Cancer
8%
Digital Intervention
8%
Home-based
8%
Ethnic Minorities
8%
Paramedic
8%
Medication Adherence
8%
National Institutes of Health
8%
Buprenorphine Treatment
8%
Medications for Opioid Use Disorder
8%
Usual Care
8%
Informal Caregivers
7%
Expert Workshop
7%
COVID-19 Risk
7%
Feasibility Randomised Controlled Trial
7%
Service Users
7%
Method Analysis
7%
Recovery Period
7%
Neighborhood Belonging
7%
Scoping Review
7%
Healthcare Domain
7%
Technostress
7%
Policy Principles
7%
Medicine and Dentistry
Randomized Controlled Trial
100%
Health Care Cost
57%
Cost-Effectiveness Analysis
42%
COVID-19
37%
Quality of Life
35%
Emergency Care
31%
Systematic Review
28%
Medicine
28%
Care Pathway
22%
Health Care
22%
e-Health
22%
Clinician
20%
Frontal Variant Frontotemporal Dementia
20%
Primary Progressive Aphasia
20%
Posterior Cortical Atrophy
20%
Malignant Neoplasm
19%
Drug Therapy
19%
National Health Service
17%
Health Technology
16%
Clinical Decision Making
16%
Clinical Trial
16%
Patient Preference
15%
Mental Health
15%
Mobile Health
15%
Medication Compliance
15%
Nurse
15%
Buprenorphine
15%
Diseases
14%
Deterioration
14%
Emergency Department
13%
Awareness
12%
Arm
11%
Cancer Diagnosis
11%
Intention-to-Treat Analysis
11%
Self Concept
11%
Quality Adjusted Life Year
11%
Behavioral Change
11%
Patient Referral
11%
Epileptic Seizure
11%
Base
11%
Outcome Assessment
11%
Care Group
11%
Peer Group
11%
Medical Science
11%
Public Health
11%
Acute Disease
11%
Health Service
10%
Personal Experience
10%
Cohort Studies
10%
Vital Sign
10%
Diagnosis
9%
Comorbidity
9%
Observational Study
9%
Medical Record
9%
Primary Health Care
9%
Mental Capacity
8%
Health Outcomes
8%
Adverse Event
8%
Stakeholder Engagement
8%
Mixed Methods
8%
Wellbeing
8%
Technology Assessment
8%
Patient Care
8%
Hospital Inpatient
8%
Umbrella Review
7%
Health Care Personnel
7%
Healthcare Professional
7%
Protocol Compliance
7%
Prognostic Factor
7%
Secondary Research
7%
Blood Plasma
7%
Vaginal Discharge
7%
Proteomics
7%
Ambulance
7%
Remote Sensing
7%
Eye Examination
7%
Dentist
7%
Pediatric Epilepsy
7%
Biological Marker
7%
Maturity Onset Diabetes of the Young
7%
Uterine Cancer
7%
Postpartum Depression
7%
Symptom Management
7%
Cognitive Bias
7%
Research Design
7%
Antisocial Personality Disorder
7%
Community Pharmacy
7%
Exploratory Factor Analysis
7%
Phase III Trials
7%
Burnout
7%
Heart Rate Variability
7%
Biometry
7%
Liraglutide
7%
Depressive Disorder
7%
Long-Term Care
7%
Histopathology
7%
Circadian Rhythm
7%
Immune Checkpoint Inhibitor
7%
Health
7%
Brain Ventricle Peritoneum Shunt
7%